Crystal structure of the tyrosine phosphatase SHP-2
- PMID: 9491886
- DOI: 10.1016/s0092-8674(00)80938-1
Crystal structure of the tyrosine phosphatase SHP-2
Abstract
The structure of the SHP-2 tyrosine phosphatase, determined at 2.0 angstroms resolution, shows how its catalytic activity is regulated by its two SH2 domains. In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site. This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft. Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface. Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme. Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.
Similar articles
-
Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.J Immunol. 2000 Aug 1;165(3):1344-51. doi: 10.4049/jimmunol.165.3.1344. J Immunol. 2000. PMID: 10903736
-
Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2.Structure. 1998 Mar 15;6(3):249-54. doi: 10.1016/s0969-2126(98)00027-6. Structure. 1998. PMID: 9551546 Review.
-
Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1.Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):1141-5. doi: 10.1073/pnas.93.3.1141. Proc Natl Acad Sci U S A. 1996. PMID: 8577729 Free PMC article.
-
The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.Cell Signal. 2007 Mar;19(3):600-9. doi: 10.1016/j.cellsig.2006.08.010. Epub 2006 Sep 1. Cell Signal. 2007. PMID: 17027227
-
SH2 domains: a question of independence.Curr Biol. 1996 Feb 1;6(2):125-7. doi: 10.1016/s0960-9822(02)00440-2. Curr Biol. 1996. PMID: 8673454 Review.
Cited by
-
Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function.Blood. 2013 May 16;121(20):4205-20. doi: 10.1182/blood-2012-08-449272. Epub 2013 Mar 18. Blood. 2013. PMID: 23509158 Free PMC article.
-
Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet function.Sci Signal. 2012 Oct 30;5(248):ra78. doi: 10.1126/scisignal.2002936. Sci Signal. 2012. PMID: 23112346 Free PMC article.
-
Structural and mechanistic insights into LEOPARD syndrome-associated SHP2 mutations.J Biol Chem. 2013 Apr 12;288(15):10472-82. doi: 10.1074/jbc.M113.450023. Epub 2013 Mar 1. J Biol Chem. 2013. PMID: 23457302 Free PMC article.
-
Targeting a Pathogenic Cysteine Mutation: Discovery of a Specific Inhibitor of Y279C SHP2.Biochemistry. 2020 Sep 22;59(37):3498-3507. doi: 10.1021/acs.biochem.0c00471. Epub 2020 Sep 8. Biochemistry. 2020. PMID: 32871078 Free PMC article.
-
Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation.ChemMedChem. 2024 Apr 2;19(7):e202300669. doi: 10.1002/cmdc.202300669. Epub 2024 Feb 6. ChemMedChem. 2024. PMID: 38233347 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous